GHO Capital Partners LLP’s Post

How RxPack can be a way for European pharma companies to have a more robust and reliable supply chain in the concentrated industry of pMDIs.

How RxPack can be a way for European pharma companies to have a more robust and reliable supply chain in the concentrated industry of pMDIs:

According to reports big pharma are set to lose $200bn in annual revenues due to the 'patent cliff' that has already begun. We expect M&A activity to increase significantly as pharma look to develop new patent worthy blockbusters and maintain market share. Let us know if the comments what your thoughts are on the cliff.... #industrynews #bigpharma #patentcliff

Did you watch our newest podcast from PharmaSource? We were joined by our VP of Global Contract Manufacturing at Pfizer CentreOne Thomas P Wilson, who discusses how we leverage our Pfizer experts to make us an ‘altogether different kind of CDMO to help bring your products to patients at speed. Here's what you will learn about how we serve our customers: ✅ Our clients have access to the same manufacturing work centers, scientists, and analysts that Pfizer uses for its products. ✅ How we leverage Pfizer's expertise and state-of-the-art global facilities ✅ How we place patient-centricity at the core of our CDMO operations. Tune in to learn about our innovative approach to contract manufacturing. 👇 #CDMO #DrugDevelopment #DrugManufacturing

Thoughts on this? >> Merck KGaA stays positive on CDMO arm’s future despite first-quarter slump >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #biotech #pharma #healthcare #pharmaceutical

Pfizer CentreOne, the 'altogether different kind of CDMO' is joining us at #CDMOLive! Ahead of the event we sat down with Thomas P Wilson, VP of Global Contract Manufacturing at Pfizer CentreOne, to discuss how their integrated business model sets them apart from other contract manufacturing partners. “Pfizer spends over a billion dollars every year to maintain our global network of 38 plants.” says Tom. “When we bring a client partner on board, they get access to the same manufacturing work centres, scientists, and analysts that Pfizer uses for its products. We have robust ways of controlling intellectual property, ensuring we’re protecting our clients and our own IP.” Unlike a pure play contract development and manufacturing partner, CentreOne don’t own their own plants and pharmaceutical development centres. Instead their customers can leverage the wealth of expertise and state-of-the-art facilities Pfizer possesses. "Pfizer’s mission statement is ‘time is life’. We bring that patient centricity to our CDMO practice. Clients are usually surprised that we’re not talking immediately about our technology, but instead about their patient’s journey, then how can we help make a difference.” ▶ Listen to the full episode here: https://lnkd.in/dEHwzJHH

Reverse Supply Chain in Pharma: A Comedy of Errors and Solutions Uncover the comedic chaos and innovative solutions of the Reverse Supply Chain in Pharma. From the tangled returns to the promising future, this blog has it all. https://lnkd.in/d5SuVx4g

Let’s hear it out from Henny Zijlstra, the Chief Commercial Officer of Adragos Pharma, who discusses why they aren’t just a standard and regular CDMO but have a disruptive and non-conventional approach that paves the path for organizations to partner with them. #AdragosPharma #CDMOinnovation #HennyZijlstrainterview #disruptiveCDMOapproach #pharmaceuticalpartnerships #CDMOindustrytrends #worldpharmatoday

Are we witnessing a new "Age of the CDMO"? Over the past few years, the #pharma / #biotech industry has seen a significant shift from internal to external manufacturing. In this new Outsourced Pharma article, Paul Cummings of PJC PHARMA CONSULTING LIMITED examines the driving factors and shares his perspective for what to expect in 2025 and beyond. https://lnkd.in/dMXeZA6Z #contractmanufacturing #outsourcing

It's important to find the right CDMO for the success of any pharmaceutical or biotech project. 💊💉 A good CDMO should... 🔷Bring valuable expertise and capabilities to the table, ensuring that products are developed with high quality and meet all regulatory standards. 🔷Offer insights into efficient manufacturing practices, cost-effective solutions, and cutting-edge technologies, helping to speed up the time it takes to get a product to market. 🔷Help navigate and reduce risks like compliance issues, supply chain disruptions, and quality control problems. Outsourced Pharma is helping address the difficulty of contracting CDMOs who are ready, willing, and able. Join Alcami's Tyler Ewald, MBA , Sr. Director, OSD Operations and Packaging Services, on July 24 for Outsourced Pharma Capacity Update - Small Molecule! This event is a free interactive digital event where CDMOs share their capabilities and available capacities to assist you in identifying outsourcing options. Register now ➡️https://hubs.li/Q02D1Q3k0